GlassScriptPhysician profile
Erin L Grigg
NPI 1720466238
$1,199.86
in general payments reported to CMS, 2019-2025
19 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $475 · 2022: $123 · 2023: $39.18 · 2024: $174 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.18 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $174.08 | 2021-2025 | |
| Astellas Pharma US INC | $142.11 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $114.88 | 2025 | Acessa Provu System, Novasure, Fetal Fibronectin Enzyme Immunoassay |
| Coopersurgical, INC. | $110.17 | 2024-2025 | Paragard T 380a |
| Exeltis, USA INC. | $90.95 | 2021-2023 | Slynd |
| Avion Pharmaceuticals | $74.91 | 2021 | |
| Organon LLC | $72.39 | 2021-2025 | Nexplanon |
| Evofem Biosciences, INC. | $66.95 | 2021 | |
| Myovant Sciences INC. | $56.08 | 2021-2022 | |
| Biogen, INC. | $48.59 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $42.43 | 2021-2023 | |
| Therapeuticsmd, INC. | $38.30 | 2021 | |
| Pfizer INC. | $37.19 | 2025 | |
| Boston Scientific Corporation | $32.70 | 2024 | Upsylon, Solyx Sis System |
| Millicent US INC | $28.55 | 2021-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $23.65 | 2021 | |
| Convatec INC. | $17.66 | 2021 | |
| Agile Therapeutics, INC. | $14.28 | 2024 | Twirla |
| Merck Sharp & Dohme LLC | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Grigg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.